Adam Tomich

Adam Tomich is an experienced associate CMC project manager at Cogent Biosciences, where responsibilities include facilitating IND-enabling activities and managing vendor contracts for early-phase compounds. Prior to this role, Tomich served as a principal research associate in process development and microbiology/immunology at Vedanta Biosciences, overseeing project management tasks, coordinating phase 3 manufacturing activities, and validating assays. Additional experience includes positions as a senior research associate at Spero Therapeutics and the University of Pittsburgh, where Tomich focused on antibiotic resistance research, laboratory management, and high-throughput screening for potential inhibitors. Adam Tomich earned a Bachelor of Science degree in Microbiology from the University of Pittsburgh.